Neuro3d, J&J deal

Neuro3d said that it received an exclusive license to ocaperidone from JNJ's Janssen Pharmaceutica N.V. subsidiary (Beerse, Belgium). The antipsychotic is in Phase I testing. Janssen has an option to...